Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |